Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Vericel (VCEL) over the last 16 years, with Q3 2025 value amounting to $305000.0.

  • Vericel's Gains from Investment Securities rose 1254.61% to $305000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 615.43%. This contributed to the annual value of $5.5 million for FY2024, which is 8561.12% down from last year.
  • Per Vericel's latest filing, its Gains from Investment Securities stood at $305000.0 for Q3 2025, which was up 1254.61% from $136000.0 recorded in Q2 2025.
  • Vericel's 5-year Gains from Investment Securities high stood at $33.9 million for Q2 2023, and its period low was $7000.0 during Q4 2022.
  • In the last 5 years, Vericel's Gains from Investment Securities had a median value of $271000.0 in 2024 and averaged $2.8 million.
  • In the last 5 years, Vericel's Gains from Investment Securities plummeted by 9984.36% in 2021 and then surged by 2758571.43% in 2023.
  • Quarter analysis of 5 years shows Vericel's Gains from Investment Securities stood at $46000.0 in 2021, then crashed by 84.78% to $7000.0 in 2022, then soared by 27585.71% to $1.9 million in 2023, then tumbled by 92.11% to $153000.0 in 2024, then skyrocketed by 99.35% to $305000.0 in 2025.
  • Its Gains from Investment Securities stands at $305000.0 for Q3 2025, versus $136000.0 for Q2 2025 and $6.2 million for Q1 2025.